Technology News and Research

RSS

AADR Fall Focused Symposium highlights fast-moving field of Salivary Diagnostics

The American Association for Dental Research (AADR) held its 3rd Fall Focused Symposium on November 12-13, in the Washington, DC, area. This year, the theme was the fast-moving field of Salivary Diagnostics, with a focus on Scientific & Clinical Frontiers.

23 Nov 2010

U.S mortality rate from congenital heart defects drops 24%: Report

The U.S. death rate from congenital heart defects dropped 24 percent from 1999 to 2006 among children and adults, according to research reported in Circulation: Journal of the American Heart Association.

23 Nov 2010

Medicalis to showcase Radiology Collaborative Workflow Solutions at 96th RSNA

Medicalis today announced the commercialization of its next generation Radiology Collaborative Workflow Solutions™ offering providers a sophisticated technology platform to enhance productivity and ensure the delivery of measureable high-quality radiology care. For the first time, the company will showcase its three groundbreaking Collaborative Workflow Solutions at the 96th annual meeting of the Radiological Society of North America (RSNA), Nov. 28 – Dec. 2, in Chicago (Booth 4050).

23 Nov 2010

New microchip implant enables people with paraplegia to exercise paralysed leg muscles

Engineers have developed a new type of microchip muscle stimulator implant that will enable people with paraplegia to exercise their paralysed leg muscles.

23 Nov 2010

Medicare making changes to acknowledge telemedicine's growing use

American Medical News: Through teleconferencing technology, doctors are able to treat patients who live far away without access to a specialist. "Nationwide, telemedicine increasingly is being used to bridge gaps in access to care in rural and other medically underserved communities that have a hard time recruiting physicians.

23 Nov 2010

Apricus files protocol of PrevOnco Phase 3 clinical trial for FDA SPA program

Apricus Biosciences, Inc., today announced that it has filed the protocol for a proposed Phase 3 clinical trial of PrevOnco, its proprietary treatment for hepatocellular carcinoma (liver cancer), with the U.S. Food and Drug Administration (FDA).

23 Nov 2010

Soligenix receives U.S patent for modified immunogen in RiVax vaccine

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the United States Patent and Trademark Office has granted patent #7,829,668, entitled Compositions and methods for modifying toxic effects of proteinaceous compounds.

22 Nov 2010

New simple diagnostic tool to detect dangerous viruses

Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt.

22 Nov 2010

Stem cell trial for eye disease receives FDA approval

The second clinical trial involving stem cells from human embryonic cells has received the go-ahead. The news came from Advanced Cell Technology Inc. this Monday. The company announced that the U.S. Food and Drug Administration has cleared the way for its Phase I/II trial of retinal cells for patients with Stargardt’s macular dystrophy, a childhood version of macular degeneration.

22 Nov 2010

North Sunflower Medical Center to deploy McKesson health IT solutions

As part of its mission to become the first critical access hospital in Mississippi to demonstrate meaningful use of electronic health record EHR) technology, North Sunflower Medical Center plans to deploy a suite of McKesson information technology solutions. The new systems will replace paper-based records and disparate technologies and address duplicate data entry challenges with communications capabilities designed to automate outdated manual processes and better coordinate care.

22 Nov 2010

PROTEK switches to IBM POWER7 systems

IBM today announced that Russian pharmaceutical distributor PROTEK has switched to IBM POWER7 systems for its data processing center. The new systems from IBM replace the previous servers from HP, enabling PROTEK to improve the performance of critical business applications while reducing power consumption and increasing return on investment.

22 Nov 2010

Research roundup: Health IT and malpractice; Wide variation in hospital rates; Income and insurance offerings

New England Journal of Medicine: Medical Malpractice Liability In The Age Of Electronic Health Records - "Providers can expect a varied and shifting landscape of medical liability risks and benefits as the adoption of [electronic health records] EHRs unfolds," write the authors who explore the ways EHRs may bring about long-term changes in standard of care and affect the course of malpractice litigation.

22 Nov 2010

Cerner products achieve CCHIT Complete EHR certification

Cerner Corporation announced today that PowerChart®, FirstNet®, ProFile®, HealthSentry®, Cerner Healthe, Cerner® Health Record, IQHealth® and P2Sentinel™ 2007.19.12 and P2Sentinel™ v4.2.1 is 2011/2012 compliant and was certified as a Complete EHR on Oct.28, 2010 by the Certification Commission for Health Information Technology, an Office of the National Coordinator for Health Information Technology - Authorized Testing Certification Bodies, in accordance with the applicable Hospital certification criteria adopted by the Secretary of Health and Human Services.

22 Nov 2010

FDA grants ACT clearance for Phase I/II clinical trial of hESC derived retinal cells in patients with SMD

Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.

22 Nov 2010

Helpson receives 'National High-Tech Enterprise' status

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that its wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd ("Helpson"), received the "National High-Tech Enterprise" status ("National HT Status") from the PRC government, as recognized by the Ministry of Science and Technology of China, the Ministry of Finance, and the State Administration of Taxation.

22 Nov 2010

Medisafe 1 Technologies to develop new medical locking devices for intravenous administration

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that that the company's board of directors has approved the research and development of two new medical locking device products.

22 Nov 2010

Agilent's GeneSpring Bioinformatics Solution integrated with GeneGo's MetaCore

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, and Agilent Technologies, Inc., the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications, announced today that they have integrated Agilent's GeneSpring Bioinformatics Solution with MetaCore.

22 Nov 2010

BioNeutral signs 'Stand Still' agreement with DFB

BioNeutral Group, Inc., a specialty technology-based life science company, today announced it has signed a "Stand Still" agreement with a leading pharmaceutical company, DFB Pharmaceuticals, Inc. (DFB).

From Evident Corporation - Life Sciences 22 Nov 2010

Bacterin secures $8 million financing from WTI

Bacterin International Holdings, Inc., a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that it has secured an asset based lending facility of up to $8.0 million from Western Technology Investment, and has received approximately $980,000 through the exercise of warrants for a total of approximately $9 million potentially available for the Company's use.

22 Nov 2010

Medisafe 1 presents barcoded syringe locking device at Medica 2010 Conference

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's exhibition of its barcoded syringe locking device generated overwhelming interest at the annual Medica 2010 Conference in Dusseldorf Germany, held November 16-19.

22 Nov 2010